Moroxydine

This classification denotes an anti-infective agent with the molecular formula C6H13N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O611591WAH, chemically known as 4-morpholinecarboximidamide, n- (aminoiminomethyl)-, monohydrochloride but generally known as moroxydine, which bears US NIH Compound Identifier 71655. European Medicines Agency schedules Moroxydine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09070MIG. The term MOROXYDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules moroxydine in its Anatomical Therapeutic Chemical (ATC) Classification. MOROXYDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moroxydine under HS 29349990 and SITC 51579. As of Q4 2014, MOROXYDINE remains the US FDA Preferred Term for this commodity. Moroxydine bears US NLM identifiers UMLS ID C0066805 and NCI Concept Code C66200. SMILES: O1CCN(CC1)C(=N)/N=C(/N)N.